Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND Few studies investigated socio-demographic and clinical predictors of non response and remission in treatment resistant depression (TRD) in the case of failure of more than two adequate antidepressant (AD) trial. The primary aim of this study was to investigate socio-demographic and clinical predictors of TRD defined as the lack of response to at least three adequate AD treatments, two of which prospectively evaluated. As secondary aims, we also investigated predictors of non response and remission to: (1) at least two adequate AD treatment (one of which prospectively assessed); (2) at least one adequate and retrospectively assessed AD treatment. METHODS In the context of a European multicenter project, 407 major depressive disorder (MDD) patients who failed to respond to a previous AD treatment were recruited for a 2 stage trial, firstly receiving venlafaxine and then escitalopram. MINI, HRSD, MADRS, UKU, CGI-S and CGI-I were administered. RESULTS Ninety eight subjects (27.61%) were considered as resistant to three AD treatments. Clinical predictors were: longer duration and higher severity of the current episode (p=0.004; ES=0.24; p=0.01; RR=1.41, respectively), outpatient status (p=0.04; RR=1.58), higher suicidal risk level (p=0.02; RR=1.49), higher rate of the first/second degree psychiatric antecedents (MDD and others) (p=0.04; RR=1.31, p=0.03; RR=1.32 respectively) and side effects during treatments (p=0.002; RR=2.82). Multivariate analyses underlined the association between TRD and the severity of the current episode (p=0.04). As for secondary outcomes, predicting factors were partially overlapping. LIMITATIONS The limited sample size and specific drugs used limit present findings. CONCLUSION Subjects with a high degree of resistance to AD treatments show specific features which may guide the clinicians to the choice of more appropriate therapies at baseline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705 · cited 1×
“pression (HRSD) 17-item version (Hamilton, 1960), and Clinical Global Impression Severity (CGI-S) (Guy, 1976)); (4) somatic illnesses; (5) current and (6) previous medications; (7) side effects (Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale (Lingjaerde et al., 1987)); (8) psychiatric familial antece…”
BackgroundKeller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Social Support and the Outcome of Major Depression
George, L. K., Blazer, D. G., Hughes, D. C., & Fowler, N. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.4.478 · Cited by 732 · cited 1×
“Indeed, we could speculate that an unfavorable family environment or the lack of family support, due to psychopathologies, may increase the risk of developing TRD (George et al., 1989; Leskela et al., 2006).”
BackgroundReport by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · cited 2×
“We should finally consider that traditional outcomes in clinical studies on MDD mainly focused on symptomatic improvement or response, rather than on full remission, failing to emphasize the substantial impact of residual symptoms on psychosocial dysfunction and poor prognosis (Rush et al., 2006).”
BackgroundSouery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 7×
“, 2013), while melancholic subtype of depression, suicidal behavior (Papakostas et al., 2003; Souery et al., 2007) and comorbid current or lifetime generalized anxiety disorder (Petersen et al.”
BackgroundResultInfluentialSelf-citationBerlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
Klein, D. N., Schatzberg, A. F., McCullough, J. P., Dowling, F., Goodman, D., Howland, R. H., Markowitz, J. C., Smith, C., Thase, M. E., Rush, A. J., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00020-8 · Cited by 212 · cited 2×
“Indeed, it was frequently related to early onset of MDD and chronicity, both linked to treatment resistance (Klein et al., 1999).”
BackgroundResultLESKELÄ, U., RYTSÄLÄ, H., KOMULAINEN, E., MELARTIN, T., SOKERO, P., LESTELÄ-MIELONEN, P., & ISOMETSÄ, E. (2006) · Psychological Medicine · doi:10.1017/s0033291706007276 · Cited by 105 · cited 1×
“Indeed, we could speculate that an unfavorable family environment or the lack of family support, due to psychopathologies, may increase the risk of developing TRD (George et al., 1989; Leskela et al., 2006).”
BackgroundCognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder
Fava, G. A., Savron, G., Grandi, S., & Rafanelli, C. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0608b · Cited by 92
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Self-citationMcAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Self-citationChildren’s Physical Activity and Depression: A Meta-analysis
Korczak, D. J., Madigan, S., & Colasanto, M. (2017) · Pediatrics · doi:10.1542/peds.2016-2266 · Cited by 269
Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1635270 · Cited by 152
“…al. 2018a), symptom severity (Souery et al. 2007), Balestri et al. 2016, high occupational level (Mandelli et al. 2016a, 2019), outpatient status (Balestri et al. 2016), psychotic symptoms (Zaninotto et al. 2013; Dold et al. 2019), melancholic features (Souery et al. 2007; Zaninotto et al.…”
BackgroundInfluentialSelf-citationKautzky, A., Dold, M., Bartova, L., Spies, M., Kranz, G. S., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fabbri, C., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12959 · Cited by 148
“3, a replication of previous findings by the GSRD and others (8, 22, 23).”
BackgroundResultSelf-citationDold, M., Bartova, L., Souery, D., Mendlewicz, J., Serretti, A., Porcelli, S., Zohar, J., Montgomery, S., & Kasper, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.020 · Cited by 131
Self-citationSaade, Y. M., Nicol, G., Lenze, E. J., Miller, J. P., Yingling, M., Wetherell, J. L., Reynolds, C. F., & Mulsant, B. H. (2019) · Depression and Anxiety · doi:10.1002/da.22964 · Cited by 47
Yrondi, A., Aouizerate, B., Bennabi, D., Richieri, R., D'Amato, T., Bellivier, F., Bougerol, T., Horn, M., Camus, V., Courtet, P., et al. (2020) · Depression and Anxiety · doi:10.1002/da.22997 · Cited by 37
“In addition, recurrence, persistence of depressive symptoms, and chronicity are known as risk factors of TRD (Balestri et al., 2016; Kautzky et al., 2018).”
BackgroundLähteenvuo, M., Taipale, H., Tanskanen, A., Rannanpää, S., & Tiihonen, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.010 · Cited by 20
Jensen, K. J., Gronemann, F. H., Ankarfeldt, M. Z., Jimenez-Solem, E., Alulis, S., Riise, J., Bødker, N., Osler, M., & Petersen, J. (2022) · PLOS ONE · doi:10.1371/journal.pone.0275299 · Cited by 15
Metadata
- Authors
- Balestri, M., Calati, R., Souery, D., Kautzky, A., Kasper, S., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 189
- Pages
- 224-232
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2138606641
- Cited by
- 102
- References
- 10
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.